Welcome to the new Rare Kidney Disease Show part of the RKD Scientific Network sponsored by Travere Therapeutics. The Rare Kidney Disease Show is your primary source for cutting-edge insights, expert perspectives, and pivotal updates in nephrology. Led by our panel of experts, explore the advances in glomerular nephropathies through compelling conversations, challenging case studies, and discussions tackling hot topics. Join us as we strive to provide you with the ultimate resource to suppor ...
…
continue reading
Frontier Strategy Group (FSG) is the leading information services provider for emerging markets executives. Through a robust offering of research, analytics, data and network of expertise, FSG partners with business leaders at over 200 multinationals to power their emerging markets business strategies. FSG's Emerging Markets Insights podcast series provides 20 to 30 minute briefings on markets, emerging issues, and strategic business analysis. If you would like more information about FSG's s ...
…
continue reading
A bite-size podcast brought to you by the International Society of Glomerular Disease. Nephrologists and glomerular disease experts Dr. Kenar Jhaveri (Northwell Health/Hofstra University) and Dr. Koyal Jain (UNC Chapel Hill) take a lighthearted look at the latest research, discuss clinical practice, and interview leaders in glomerular medicine — all in a short enough time to listen on your coffee break.
…
continue reading
SHOW NOTES In this episode, Koyal and Kenar recap everything you need to know about IgAN for the board exam (or just to refresh yourself on the current state of knowledge) — from pathophysiology to treatment decisions. They also discover that nobody is really sure how to pronounce Peyer’s patches (hey, don’t blame us, they’re all the way over in th…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Role of Endothelin in IgAN, ft. Dr. Donald Kohan : 3
17:25
17:25
Play later
Play later
Lists
Like
Liked
17:25
Episode Overview: Donald Kohan, PhD is an Emeritus Professor at the University of Utah Health with expertise in endothelin receptors, sodium transporters, and the renin-angiotensin-aldosterone system in chronic kidney disease. In this episode, Professor Kohan provides an overview of the endothelin system and how it relates to the pathophysiology of…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 7: Felicitas Hengel and Nicola Tomas on a New Chapter in Anti-Nephrin Autoantibodies
16:15
16:15
Play later
Play later
Lists
Like
Liked
16:15
In this episode, we talk with Dr. Felicitas Hengel, MD and Dr. Nicola Tomas, MD (both at the University Medical Center Hamburg-Eppendorf) about their groundbreaking anti-nephrin autoantibody research that was just presented at the 2024 ERA Congress and published in the New England Journal of Medicine. Is this a game-changer for minimal change? How …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 6: Astrid Weins on Anti-Nephrin Antibodies and Nephropathology
17:23
17:23
Play later
Play later
Lists
Like
Liked
17:23
In this episode, Kenar and Koyal interview Dr. Astrid Weins, MD, PhD, about nephropathology, new approaches to solving the mysteries of nephrotic syndrome, and her research on anti-nephrin antibodies in minimal change disease. Dr. Weins is Chief of Integrated Renal Pathology at Mass General/Brigham and an Assistant Professor of Pathology at Harvard…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 5: Industry Perspective with Jula Inrig: Endothelin Antagonism, IgAN, FSGS, Clinical Trial Career Paths, and the New Era of Nephrology Trials
24:54
24:54
Play later
Play later
Lists
Like
Liked
24:54
In this episode, Kenar and Koyal talk with Dr. Jula Inrig about endothelin physiology and different approaches to endothelin antagonism, trials of sparsentan in IgAN and FSGS, the art and science of clinical trial design, career paths in clinical research outside academia, and how we got to our current era of plentiful nephrology clinical trials. D…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Unmet Needs in IgAN: Burden of Disease & Long-Term Impact on Patients ft. Dr. Jonathan Barratt : 2
15:44
15:44
Play later
Play later
Lists
Like
Liked
15:44
Overview: In this episode of the Rare Kidney Disease Show, Professor Jonathan Barratt discusses the need to take a long-term approach when managing IgA nephropathy patients. He presents data from the UK National Registry of Rare Kidney Diseases (RaDaR). During this recording you will hear Professor Barratt discussing the continued risk of progressi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Getting Ahead of IgAN: A New Treatment Paradigm for Disease Control ft. Dr. Brad Rovin : 1
16:15
16:15
Play later
Play later
Lists
Like
Liked
16:15
Overview: In this episode of the Rare Kidney Disease Show, Dr. Rovin, Professor of Internal Medicine and Pathology at Ohio State University and chair of the RKD Scientific Network and Podcast, discusses advances in the management of IgAN through a patient case study. “IgAN progresses more often than we thought and progresses even in patients with l…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 4: NephMadness Special! Anna Burgner on Preeclampsia
20:01
20:01
Play later
Play later
Lists
Like
Liked
20:01
It's March, and that means it's time for NephMadness! Every year, our friends at AJKDBlog pit 16 unique regions of nephrology against each other in a basketball-style tournament. Prepare for the Preeclampsia region by listening to this special episode, where Anna Burgner from Vanderbilt University joins Kenar and Koyal to discuss recent discoveries…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 3: Opeyemi Olabisi on APOL1-Mediated Kidney Disease and Community Engagement
15:28
15:28
Play later
Play later
Lists
Like
Liked
15:28
We talk with Dr. Opeyemi Olabisi, MD, PhD, about the history and future of APOL1-mediated FSGS, the role of clinical researchers in building trust with patients, his innovative CARE and JUSTICE programs to bring kidney health screenings and research opportunities to the underrepresented African American community, and why his expertise as an MD/PhD…
…
continue reading
In this episode of GN in Ten, Koyal and Kenar take the show on the road to Kidney Week to ask attendees about their favorite glomerular diseases. Listen closely for a surprise Shakespearean crossover!By International Society of Glomerular Disease
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 1: Tobias Huber on ISGD and the Future of Glomerular Medicine
10:46
10:46
Play later
Play later
Lists
Like
Liked
10:46
International Society of Glomerular Disease President Prof. Dr. Tobias B. Huber of the University Medical Center Hamburg-Eppendorf discusses the mission of the society and his vision for the future of glomerular disease. More information on the Hamburg Center for Kidney Health Creators & Guests Kenar Jhaveri - Host Koyal Jain - Host Tobias B. Huber…
…
continue reading
Welcome to GN in Ten from the International Society of Glomerular Disease! In this trailer, our hosts Dr. Kenar Jhaveri and Dr. Koyal Jain introduce themselves and the podcast. Learn more about the International Society of Glomerular Disease (ISGD) at is-gd.org.By International Society of Glomerular Disease
…
continue reading
DuckerFrontier's CEO, Richard Leggett, and Analyst for Southeast Asia, Ashu Agarwal, discuss the research report on “Channel Design in ASEAN”, including how Southeast Asia fits within MNCs APAC portfolio, key factors to identify an ideal go-to-market strategy for the ASEAN markets, and common approaches to boost channel effectiveness.…
…
continue reading
FSG's CEO, Richard Leggett, and Practice Leader for South Asia, Pratima Singh, discuss the recently released report on “Winning in a More Competitive India”, including the current outlook for the economy, the four key factors driving increased competition, FSG’s Four P’s strategic framework, and 10 tactics that help MNCs outperform in an increasing…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
European Populism: A risk or an opportunity for MNCs?
31:33
31:33
Play later
Play later
Lists
Like
Liked
31:33
Mark McNamee - Europe Practice Leader, Athanasia Kokkinogeni - WEUR Analyst and Martin Belchev - CEE Analyst discuss if MNCs should consider populism a risk, an opportunity or business-as-usual for their firms across EuropeBy Frontier Strategy Group
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Leveraging value-added services to drive market access
23:26
23:26
Play later
Play later
Lists
Like
Liked
23:26
Rising competition and payer budget challenges have resulted in continuously increasing pricing pressures for multinational healthcare (HC) companies operating in emerging markets. While investment in R&D and further sector consolidation will be important to continue driving revenue and profit growth, multinational healthcare companies have also be…
…
continue reading
FSG’s CEO, Rich Leggett, and Practice Leader for SSA, Will Attwell, discuss how multinationals can improve their performance in SSA by selling to the region’s largest customers – those in the public sector. They assess opportunities to drive new sales to this relatively under-penetrated segment, unpack the challenges and complexities involved, and …
…
continue reading
North-East Asia Senior Analyst, Josef Jelinek, and Director of Asia Pacific Research, Adam Jarczyk, discuss China's Belt and Road Initiative and its implications for multinational companies. This podcast extracts the key takeaways from FSG's recently published report of the same title, providing clarity on an opaque initiative that will wash over e…
…
continue reading
Earlier in April, FSG hosted a client webinar to discuss the latest on US-China trade tensions, NAFTA negotiations, and US steel and aluminum tariffs. This podcast extracts the key takeaways from the webinar, providing clarity on these rapidly moving global events and highlighting and the implications for your business…
…
continue reading
Western Europe Analyst, Athanasia Kokkinogeni, and Practice Leader for Europe, Mark McNamee, discuss Brexit and its implications for multinational companies. Regardless of its final outcome, the UK’s exit from the European Union will reshape the operating environment for MNCs in the UK.By Frontier Strategy Group
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Western Europe: Expect a strong Q2 without dismissing the risks
15:48
15:48
Play later
Play later
Lists
Like
Liked
15:48
Western Europe Analyst, Athanasia Kokkinogeni, and Practice Leader for Europe, Mark McNamee, discuss about the improved WEUR outlook for Q2, sharing strategic insights for executives to win in this market in transition.By Frontier Strategy Group
…
continue reading
Managing Director for FSG’s Global Channel Practice, Ryan Brier, and Practice Leader for South Asia, Pratima Singh, analyze the impact of India’s Goods and Services Tax on multinationals’ channel strategies and discuss how executives can effectively capture the gains from a changing distribution landscape.…
…
continue reading
FSG's CEO Rich Leggett and Practice Leader for South Asia Pratima Singh discuss the outlook for India over the next several months, the opportunities and risks facing the economy, the newly released government budget, and the implications for MNC executives operating in the country.By Frontier Strategy Group
…
continue reading
FSG's CEO, Richard Leggett, and Global Economics Director Antonio Martinez discuss the Events to Watch for 2018 report, including the the methodology behind the report, the events that may disrupt multinational business performance and operations, and the importance of contingency planning in emerging markets…
…
continue reading
Western European markets will record strong performance in 2018, after risks subsided during 2017. However, multinationals are unlikely to see a considerable acceleration in consumer and business demand in 2018 unless governments implement reforms. As macroeconomic conditions remain favorable, competition will increase. With careful execution and a…
…
continue reading
FSG held its annual Moscow breakfast with clients in September, where clients indicated their concerns over pressure from corporate to hit rising revenue targets in 2018 after a mild uptick in demand in 2017. However, nearly all firms noted that rising costs were a concern in the market and therefore high pressure on margins causing companies to in…
…
continue reading
FSG's CEO Richard Leggett and MENA Practice Leader Zeynep Kosereisoglu discuss how MNCs must adapt their value offering to their customers in the GCC to manage the region's economic slowdown and its increasingly complicated operating environmentBy Frontier Strategy Group
…
continue reading
Western European markets will grow by 1.7% YOY in 2017—South Europe will exceed this growth, with Spain and Portugal leading the way. South Europe suffered the most from the 2008/2009 financial and 2012/2013 debt crises, but since then has been recovering because of strong exports—primarily tourism—and consumer demand. South Europe will be an attra…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Insights from Kyiv: Rising optimism but some risks remain
24:33
24:33
Play later
Play later
Lists
Like
Liked
24:33
Ukraine has faced an extremely tumultuous period over the past three years and is beginning to recover and exit its recession. As MNCs are increasingly trying to anticipate the outlook for the market in the coming years and make strategic decisions regarding investments in the country, Ukraine is starting to return to focus. Our Senior Analyst for …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
A strengthening outlook for Western Europe
21:21
21:21
Play later
Play later
Lists
Like
Liked
21:21
Political uncertainty subsides for the region, and economic fundamentals slowly strengthen, creating additional opportunities for multinationals. However, an acceleration in growth beyond current levels is unlikely, as unemployment remains high and reforms are slow. In this podcast, FSG's Western Europe analyst Athanasia Kokkinogeni discusses the o…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Future of Chinese Urbanization [Podcast]
23:47
23:47
Play later
Play later
Lists
Like
Liked
23:47
China is currently undergoing a once-in-a-lifetime transition to a consumption- and services-based growth model. To facilitate this transition, the government has embarked on an ambitious urbanization drive to turn tens of millions of rural farmers into urban consumers. The government has a detailed blueprint outlining how it intends to implement t…
…
continue reading
FSG's CEO Rich Leggett and Director for Global Economics Antonio Martinez discuss the outlook for the healthcare industry in Latin America, focusing on the short-term outlook, long-term opportunities and challenges, and strategies for success in a changing landscape for pharmaceutical and medical device companies.…
…
continue reading
Western European markets are recovering at a moderate pace as market conditions gradually improve. However, a number of downside risks in the political sphere and the region’s banking sector will weigh on business and consumer confidence during 2017, making planning more complex for multinational companies looking to accelerate growth in the region…
…
continue reading
Mexico confronts potential disruptions to its economic model due to the renegotiation of NAFTA and the increasing likelihood of a populist president coming to power in 2018. FSG's Director for Global Economics Antonio Martinez discusses what's next for Mexico and how multinationals can prepare for persistent uncertainty over the coming year.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
South Africa - What's Next after the Government Reshuffle
21:18
21:18
Play later
Play later
Lists
Like
Liked
21:18
After a turbulent week with a government reshuffle and sovereign ratings downgrades, executives need to adjust expectations about South Africa, but also assess which aspects of the market environment are likely to remain unchanged. In this podcast, FSG's Senior Analyst for Sub-Saharan Africa William Attwell discusses what's next for the market and …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
EMEA outlook: risks and opportunities in Q2 2017 and beyond
21:57
21:57
Play later
Play later
Lists
Like
Liked
21:57
FSG's CEO Rich Leggett and EMEA Research Managing Director Martina Bozadzhieva discuss the outlook for EMEA over the next several months, and the risks EMEA leadership teams should be monitoring that could derail relatively strong economic performance in Q1 2017. They also cover emerging opportunities across the region, with a focus on Sub-Saharan …
…
continue reading
FSG's CEO, Richard Leggett, and Practice Leader for South Asia, Pratima Singh, discuss the India Subnational Prioritization report, including the importance of state-level prioritization in India, the methodology, and the main findings of the state prioritization exercise.By Frontier Strategy Group
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Russia through 2020: implications for multinationals
17:11
17:11
Play later
Play later
Lists
Like
Liked
17:11
Senior Analyst for Russia, Mark McNamee, and Western Europe Analyst Athanasia Kokkinogeni, discuss Russia's medium-term political and economic outlook. As multinationals review their three- to five-year plans for Russia, it's essential for them to link these macro trends to both the risks and opportunities their businesses would need to navigate ov…
…
continue reading
FSG's CEO, Richard Leggett, and Southeast Asia Analyst Chua Cheng Siew, discuss the outlook for Vietnam as it implements reforms to improve business conditions. They examine the drivers behind the country's fast growing economy, as well as the trends and risks in an increasingly urbanized Vietnam.By Frontier Strategy Group
…
continue reading
FSG's CEO, Richard Leggett and Managing Director for FSG's Global Channel Practice, Ryan Brier, discuss the management interventions that tend to yield the greatest improvements in distributor performance in emerging markets.By Frontier Strategy Group
…
continue reading
FSG's CEO, Richard Leggett, and Senior SSA Analyst William Attwell, discuss the outlook for Ethiopia as it recovers following a period of political unrest and severe drought. They assess the drivers behind the country’s robust economic growth, examining how MNCs can capitalize on the country’s 100-million strong population, and the government’s amb…
…
continue reading
FSG's CEO, Richard Leggett, and Global Economics Practice Leader Antonio Martinez discuss the Events to Watch for 2017 report, including the the methodology behind the report, the events that may disrupt multinational business performance and operations, and the importance of contingency planning in emerging markets…
…
continue reading
FSG's Middle East & North Africa team discusses the recent economic reforms in Egypt and their impact on MNCs' pricing strategies in the market.By Frontier Strategy Group
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Implications of OPEC Deal for MENA and Qatar's 2017 Outlook
18:44
18:44
Play later
Play later
Lists
Like
Liked
18:44
FSG's CEO Richard Leggett and lead MENA Analyst Zeynep Kosereisoglu discuss the implications of the OPEC deal for MENA markets and the Outlook for Qatar in 2017By Frontier Strategy Group
…
continue reading
The market is set to exit its severe slowdown in 2017 thanks to a minimal increase in energy prices and rising public investment. MNCs can get ahead of the competition to capitalize on growing opportunities into 2018 by increasing their focus on their channel and targeting more resilient customer segments…
…
continue reading
As Russia exits its two-year recession, primarily thanks to the mild rise in energy prices, MNCs will see very gradual improvements in the market in the next 12 months. Consumer and business demand will only increase moderately as inflation slows and industrial activity picks up minimally. Firms should ecxpect increasingly conservative government s…
…
continue reading
FSG's CEO, Richard Leggett, and Global Economics Practice Leader Antonio Martinez discuss the Global Outlook for 2017, including the trajectory for the emerging global growth drivers, the priority actions for multinationals, and the outlook for major markets and geographies in 2017.By Frontier Strategy Group
…
continue reading
The minor rise in oil prices in 2017 will limit growth across CIS. The major energy exporters will continue to struggle because of their over-reliance on energy revenues while energy importers will see growth rebound more strongly. MNCs should focus on customer segmentation while identifying opportunities in smaller markets with stronger growth pot…
…
continue reading